Unspecified Kinase

Kinases are a vast family of enzymes responsible for phosphorylation, the process of transferring a phosphate group from a high-energy donor like ATP to a specific substrate [1]. This biochemical reaction acts as a molecular switch, regulating a wide array of cellular processes including signal transduction, cell division, and metabolic pathways [2]. The human genome encodes over 500 kinases, collectively known as the kinome, which are critical for maintaining cellular homeostasis [3]. Dysregulation or mutation of specific kinases is a primary driver in numerous pathologies, most notably in oncology, where they promote aberrant cell proliferation and survival [4]. While kinases are among the most important classes of drug targets, the term "Unspecified Kinase" is a generic descriptor that does not refer to a single therapeutic entity [5]. Effective drug discovery requires identifying a specific kinase member to ensure target engagement and minimize off-target toxicity [6]. Consequently, this term is typically used as a placeholder in databases when the specific isoform or family member has not yet been identified or disclosed [7]. In a clinical context, targeting an unspecified kinase would be impossible due to the high risk of systemic toxicity and lack of predictable efficacy [8].

Other names

KinasePhosphotransferaseProtein kinaseATP-dependent phosphotransferase

Kinases catalyze the transfer of the gamma-phosphate group from ATP (or other nucleoside triphosphates) to the hydroxyl group of specific amino acid residues or other substrates [1, 2].